The new Pediatric Medical Research Unit tests new medicines to treat children and teens with serious illnesses
Only 30% of all medicines today have been tested and approved for use in children. This means that children with rare and serious illnesses often have no access to evidence-based and safe treatments. To address this, The Foundation has supported the establishment of the Pediatric Medical Research Unit at Rigshospitalet. Here, children and teens can participate in clinical trials that develop and test new treatments – from gene therapies to precision medicine.
Because conducting clinical drug trials requires large capacity and a strong infrastructure, many clinical trials at Rigshospitalet are currently rejected due to a lack of staff and infrastructure.
Promising Advances
- New gene therapies show potential to correct genetic defects
- Research has improved the quality of life for children who previously had no treatment options
- International studies support the approval and broader availability of new medicines
The donation from the Foundation for Mary Elizabeth's Hospital makes it possible to gather and strengthen the area with more skills and resources. The unit's work will result in new medicine being tested on children and made available to a wider range of children.
TILMELD DIG BØRNERIGET FONDENS NYHEDSBREV
Få et unikt indblik i historier, oplevelser og fremskridt, mens vi sammen er med til at forme fremtidens børnehospital.
